Related Experiment Video

Updated: Aug 7, 2026

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Fetal haematocrit is a determinant of placental size in term pregnancies

Karen K L Chan1, Terence T Lao

  • 1Department of Obstetrics and Gynaecology, University of Hong Kong, Hong Kong, SAR, China. karenchan@pobox.com

Acta Haematologica
|July 1, 2006
PubMed

Placental size may be influenced by maternal factors, placental function as well as the fetal condition. So far, no studies have examined how the fetal oxygen-carrying capacity or haemoglobin/haematocrit levels would affect placental growth in normal human pregnancies. The aim of this study was to investigate the relationships between placental size and fetal arterial cord blood haemoglobin and haematocrit levels at the time of caesarean delivery. Umbilical arterial cord blood was taken for arterial haemoglobin and haematocrit levels immediately after delivery. The relative placental size (defined by the ratio of placental weight to fetal weight) was inversely correlated with both arterial haemoglobin (r = -0.455, p = 0.001) and haematocrit levels (r = -0.425, p = 0.003) in women who had undergone elective caesarean sections. No significant correlation was found between the relative placental size with other maternal and fetal factors.

More Related Videos

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...